12.08 USD
↘ 0.89 (6.86%)AT CLOSE (03:59 PM EDT)
Biohaven Ltd.
BHVNNYSE • USD
12.18
↗ 0.10 (0.83%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
12.18
↗ 0.10 (0.83%)
Market: CLOSED
Biohaven Ltd. (BHVN) trades at $12.00 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 6, 2026.
Open?$13.00
High?$13.04
Low?$11.88
Prev. Close?$12.97
Volume?3.1M
Avg. Volume?3.4M
VWAP?$12.16
Rel. Volume?0.91x
Bid / Ask
Bid?$12.14 × 100
Ask?$12.26 × 200
Spread?$0.12
Midpoint?$12.20
Valuation & Ratios
Market Cap?2.0B
Shares Out?151.0M
Float?119.4M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?160.29
EPS?-$3.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Themes
Employees
274
Market Cap
2.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-09-23
Address
215 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-404-0410
NEW HAVEN, CT 06510
Phone: 203-404-0410
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.90Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?17.13%High
Short Interest?20.4M
Days to Cover?6.5
Free Float119.4M
Avg Daily Volume3.1M
Settlement Date2026-09-15
Financial Health
Current Ratio?4.73Strong
Quick Ratio?4.73Strong
Cash Ratio?3.80Strong
Debt/Equity?21.23High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?160.29HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-4,801.5%WEAK▾
S&P3
ROA?-158.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-511870000
Enterprise Value?$2.0B
Fundamentals ratios updated end of day